Doctor profile · Federal record
Dr. MURTAZA BHURIWALA, MD
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · Hematology & Oncology Physician · TOMBALL, TX
- NPI 1730142068
- Accepts Medicare
- MIPS 73.5 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 4 locations .
- Primary practice
-
506 GRAHAM DR STE 120
TOMBALL, TX 773753348
(281) 516-0236
fax (281) 719-5930 - Additional location
-
22710 Professional Dr Ste 100
Kingwood, TX 773396009
(281) 358-2850
fax (281) 358-2817 - Additional location
-
522 Timberdale Ln
Houston, TX 770903063
(281) 440-5006
fax (281) 719-5935 - Additional location
-
9319 Pinecroft Dr Ste 100
The Woodlands, TX 773803485
(281) 298-8884
fax (281) 719-5936 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Show 1 more location
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- October 15, 2025
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L5991
- Medicaid
- TX #162338102
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730142068. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
93,901
Distinct HCPCS
10
Medicare allowed
$698,367
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 57,750 | 32 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,300 | 13 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 12,240 | 18 | $23 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,100 | 40 | $0 | |
88185 |
Flow cytometry technique for dna or cell analysis, each additional marker | 1,495 | 42 | $24 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 574 | 187 | $90 | |
96372 |
Injection of drug or substance under skin or into muscle | 545 | 46 | $14 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 495 | 13 | $0 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 197 | 23 | $29 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 185 | 74 | $128 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 3,611. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$8,632
Transactions
149
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3 | $3,570.00 | |
| Janssen Biotech, Inc. | 10 | $1,962.06 | |
| E.R. Squibb & Sons, L.L.C. | 32 | $397.96 | |
| Novartis Pharmaceuticals Corporation | 26 | $383.09 | |
| Celgene Corporation | 12 | $300.80 | |
| PFIZER INC. | 19 | $294.05 | |
| Eisai Inc. | 13 | $248.88 | |
| JAZZ PHARMACEUTICALS INC. | 5 | $155.64 | |
| ABBVIE INC. | 7 | $151.82 | |
| Merck Sharp & Dohme LLC | 4 | $100.92 | |
| Gilead Sciences, Inc. | 4 | $99.44 | |
| Daiichi Sankyo Inc. | 4 | $99.19 | |
| GENZYME CORPORATION | 4 | $94.90 | |
| AstraZeneca Pharmaceuticals LP | 3 | $75.27 | |
| TerSera Therapeutics LLC | 3 | $71.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,045
Patients
213
Total drug cost
$2,350,295
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 186 | 43 | $5,536 |
| Eliquis (Apixaban) | Brand | 141 | 28 | $90,789 |
| Letrozole | Generic | 134 | 19 | $3,065 |
| Pantoprazole Sodium | Generic | 69 | 18 | $407 |
| Xarelto (Rivaroxaban) | Brand | 62 | 11 | $45,902 |
| Gabapentin | Generic | 57 | 17 | $764 |
| Calquence (Acalabrutinib Maleate) | Brand | 54 | 0 | $844,236 |
| Levothyroxine Sodium | Generic | 50 | 13 | $682 |
| Prednisone | Generic | 49 | 22 | $250 |
| Xtandi (Enzalutamide) | Brand | 47 | 0 | $692,503 |